Ahmadinejad inaugurates national projects

TEHRAN (FNA)- Iranian President Mahmoud Ahmadinejad inaugurated several macro-scale national projects related to biological sciences, pharmaceuticals and medical equipment.

The projects inaugurated by President Ahmadinejad in a ceremony included launching the production line of seasonal influenza vaccine, production of 12 effective medicinal substances which were previously imported to the country and production of a number of medical equipment.

The projects were launched by knowledge-based companies of Pardis Tech Park near Tehran.

Iranian Vice-President for Science and Technology Nasrin Soltankhah accompanied the president in the ceremony.

Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.

President Ahmadinejad unveiled five new home-made radiomedicines in a ceremony in April.

The radiomedicines were developed and produced by Iranian experts at the Atomic Energy Organization of Iran (AEOI) and with the cooperation of the presidential office for science and technology.

Also in April, the Iranian vice-president for science and technology said, “Five radiomedicines, in whose production the Atomic Energy Organization has played the central role, will be unveiled by the end of Farvardin (mid April).”

She explained that the new radiomedicines are used for “diagnosing and curing refractory diseases, cancer in particular.”

In February, AEOI Chief Fereidoun Abbasi announced that Iran is due to unveil 8 new radiomedicines with applications for diagnosis, prevention and treatment of a number of diseases.

“We have produced a number of radiomedicines before, and at present we have 5 new radiomedicines under production,” Abbasi said at a ceremony in Tehran at the time.

“They (the new radiomedicines) should pass clinical verifications and then obtain the necessary license from the Health Ministry before they can be unveiled and supplied to the market,” he added.

By Fars News Agency


The Iran Project is not responsible for the content of quoted articles.